Potential uses of corticotropin-releasing hormone antagonists.
Corticotropin-releasing hormone (CRH), its natural homologs urocortins (UCN) 1, 2, and 3, and several types of CRH receptors (R), coordinate the behavioral, endocrine, autonomic, and immune responses to stress. The potential use of CRH antagonists is currently under intense investigation. Selective antagonists have been used experimentally to clarify the role of CRH-related peptides in anxiety and depression, addictive behavior, inflammatory disorders, acute and chronic neurodegeneration, and sleep disorders, as well as preterm labor.
Zoumakis
E
E
Choremeion Research Laboratory, First Department of Pediatrics, Athens University Medical School, Aghia Sophia Children's Hospital, Athens 11527, Greece.
Rice
K C
KC
Gold
P W
PW
Chrousos
G P
GP
D000818:Animals; D001007:Anxiety / Q000188:drug therapy; D003346:Corticotropin-Releasing Hormone / Q000037:antagonists & inhibitors* / Q000378:metabolism / Q000627:therapeutic use; D003863:Depression / Q000188:drug therapy; D006801:Humans; D008251:Macaca; D019964:Mood Disorders / Q000188:drug therapy; D019636:Neurodegenerative Diseases / Q000188:drug therapy; D011743:Pyrimidines / Q000494:pharmacology; D011758:Pyrroles / Q000494:pharmacology; D018019:Receptors, Corticotropin-Releasing Hormone / Q000037:antagonists & inhibitors / Q000378:metabolism; D054832:Urocortins
D011743:Pyrimidines; D011758:Pyrroles; D018019:Receptors, Corticotropin-Releasing Hormone; D054832:Urocortins; C103016:antalarmin; D003346:Corticotropin-Releasing Hormone